KLK3 and posterior cortical atrophy: In addition to efforts on improved treatment and primary prevention of PCa, prostate-specific antigen (PSA) screening has long been recognized as an effective strategy to reduce the burden of PCa and has been widely used in Western countries for decades (Arsov et al., 2022).